Targeting triple-negative breast cancer: optimising therapeutic outcomes-Reference-Cited by-同舟云学术

Targeting triple-negative breast cancer: optimising therapeutic outcomes

Published:2012-09 Issue:9 Volume:23 Page:2223-2234
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gelmon K.,Dent R.,Mackey J.R.,Laing K.,McLeod D.,Verma S.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/9/2223/13788714/mds067.pdf

Reference119 articles.

1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J Clin Invest,2011

2. Transcriptome analysis of triple negative breast cancers identifies six distinct biological subgroups and reveals therapeutic strategies;Lehmann;Cancer Res,2010

3. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001

4. The molecular portraits of breast tumors are conserved across microarray platforms;Hu;BMC Genomics,2006

5. Molecular stratification of triple-negative breast cancers;Perou;Oncologist,2011

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Mechanisms of Apoptosis Induction by Deep‐Sea‐Derived Polyketide‐Terpenoid Hybrids from Penicillium allii‐sativi: A Focus on Mitochondrial and mTOR Pathways;Chinese Journal of Chemistry;2024-08-26

2. New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer;Cancers;2024-06-28

3. Combination of Etoposide and quercetin-loaded solid lipid nanoparticles Potentiates apoptotic effects on MDA-MB-231 breast cancer cells;Heliyon;2024-06

4. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway;Journal of Cancer Research and Clinical Oncology;2024-03-25

5. Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibition;2023-12-12